Found 9 matching trials
Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL) NA This phase II trial studies how well radical-dose image guided radiation th...
Show More Location
Stanford University, School of Medicine
Learn More & Join Trial
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. PHASE2 Melanoma remains a common cancer with rising incidence, and despite signifi...
Show More Learn More & Join Trial
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers PHASE2 This phase II trial compares therapeutic plasma exchange followed by enfort...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
Endoscopic Ultrasound Radiofrequency Ablation and Immunotherapy Pembrolizumab for Locally Advanced Unresectable and Metastatic Pancreatic Duct Adenocarcinoma PHASE2 The purpose of this study is to perform a pilot phase II trial to evaluate ...
Show More Location
The University of Texas Health Science Center at Houston
Learn More & Join Trial
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases PHASE3 The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy ...
Show More Learn More & Join Trial
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial PHASE2 This phase II trial tests the impact of biomarkers in predicting initial tr...
Show More Location
CTCA at Western Regional Medical Center
Learn More & Join Trial
Combination Immunotherapy Treatment for Locally Advanced Unresectable or Metastatic, PD-L1 Negative (CPS<10), gBRCA Negative, Triple Negative Breast Cancer Including BreakVax ImmunoTreatment (Designed and Manufactured Per Patient), Chemotherapy and Anti PD-1 Therapy PHASE1 The objective of this study is to evaluate the safety, feasibility, and pre...
Show More Location
Miami Herbert Wertheim Cancer Institute
Learn More & Join Trial
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer PHASE2 This is a 3-arm study stratified by plasma ctDNA. Patients with residual TN...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas PHASE2 This study will assess the therapeutic efficacy of the combination of Laser...
Show More Learn More & Join Trial